Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
Gastroenterology
|
August 27, 2018
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8<sup>+</sup> T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim, Gi-Won Song, Seongyeol Park, et al.
Breast Cancer Research : BCR
|
January 12, 2023
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
Chang Gon Kim, Min Hwan Kim, Jee Hung Kim, et al.
Cancer Research and Treatment
|
October 5, 2018
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
Min Hwan Kim, Xianglan Zhang, Minkyu Jung, et al.
Nuclear Medicine and Biology
|
April 23, 2015
Adenovirus-mediated expression of human sodium-iodide symporter gene permits in vivo tracking of adipose tissue-derived stem cells in a canine myocardial infarction model
Ah Ra Lee, Sang Keun Woo, Sung Keun Kang, et al.
Cancer Research and Treatment
|
April 13, 2023
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
Seul-Gi Kim, Min Hwan Kim, Sejung Park, et al.
JAMA Network Open
|
November 15, 2023
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Masato Takahashi, Javier Cortés, Rebecca Dent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2023
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 28, 2014
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
Min Hwan Kim, Hyo Sup Shim, Dae Ryong Kang, et al.
British Journal of Cancer
|
April 3, 2020
Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
Min Hwan Kim, Jae-Hwan Kim, Ji Min Lee, et al.
JAMA Oncology
|
July 7, 2022
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
Hee Kyung Ahn, Sung Hoon Sim, Koung Jin Suh, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
Gastroenterology
|
August 27, 2018
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8<sup>+</sup> T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim, Gi-Won Song, Seongyeol Park, et al.
Breast Cancer Research : BCR
|
January 12, 2023
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
Chang Gon Kim, Min Hwan Kim, Jee Hung Kim, et al.
Cancer Research and Treatment
|
October 5, 2018
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
Min Hwan Kim, Xianglan Zhang, Minkyu Jung, et al.
Nuclear Medicine and Biology
|
April 23, 2015
Adenovirus-mediated expression of human sodium-iodide symporter gene permits in vivo tracking of adipose tissue-derived stem cells in a canine myocardial infarction model
Ah Ra Lee, Sang Keun Woo, Sung Keun Kang, et al.
Cancer Research and Treatment
|
April 13, 2023
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
Seul-Gi Kim, Min Hwan Kim, Sejung Park, et al.
JAMA Network Open
|
November 15, 2023
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Masato Takahashi, Javier Cortés, Rebecca Dent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2023
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 28, 2014
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
Min Hwan Kim, Hyo Sup Shim, Dae Ryong Kang, et al.
British Journal of Cancer
|
April 3, 2020
Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
Min Hwan Kim, Jae-Hwan Kim, Ji Min Lee, et al.
JAMA Oncology
|
July 7, 2022
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
Hee Kyung Ahn, Sung Hoon Sim, Koung Jin Suh, et al.
Page
of 12